KELEA
Excellerated Water
Clinical Trial
Principle:
Non-Immunological Suppression of Covid-19 Infection by Enhancing the Alternative Cellular Energy Pathway.
Registration:
ClinicalTrials.gov Identifier: NCT04490824.
Supporting Science:
https://pubmed.ncbi.nlm.nih.gov/32066365/ Additional research articles at www. mihope.org
Method:
Inhalation 5 times a day for 2 days of 5 ml nebulized water either with or without an elevated level of KELEA.*
Primary Measure:
Covid-19 PCR and/or Antigen test result at the end of the 2 days.
Secondary Measure:
Changes in Self-Reported Symptoms.
*Note it is recommended that they have the assigned product and a nebulizer on hand to quickly begin usage after positive Covid-19 PCR or Antigen testing for Covid-19.
Acknowledgments:
I understand that:
1. The use of KELEA Excellerated Water in Covid-19 infected individuals is investigational, with no proven benefits for this illness.
2. I will not delay seeking and responding to regular medical advice because of my participation in the trial.
3. It is important that I follow the instructions and that I complete the reporting requirements.
4. If I do enroll in the study, I am willing to help cover the cost of my participation.
5. No personal identifying information will be included in any publicly reported results from the study.
Application for Possible Enrollment
If you agree and wish to be considered for participation in the trial, please respond by completing and submitting the following e-mail form to keleatrial@gmail.com You will be contacted by a Study Advisor to confirm your eligibility and, if accepted into the study, you will be provided with a participant code number. You will then be able to enter the assigned number at the bottom of this page to access further information regarding the trial.